China’s Simcere Pharmaceutical Advances At Home After Exit From NYSE

“Learning and Adapting” Fuel Progress, Billionaire Chairman Ren Jinsheng Says

Read the full post on Forbes - Healthcare

Russell Flannery, Forbes Staff